A Phase II Study of Capecitabine and Docetaxel in Previously Untreated Advanced Non-Small Cell Lung Cancer Patients

This study is ongoing, but not recruiting participants.

Sponsor:

Information provided by (Responsible Party):

Tony Bekaii-Saab, Ohio State University Comprehensive Cancer Center

ClinicalTrials.gov Identifier:

NCT00201825

First received: September 12, 2005

Last updated: October 9, 2012

Last verified: October 2012

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	December 2012
Primary Completion Date:	January 2008 (Final data collection date for primary outcome measure)